View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
STR001 (Pioglitazone)
Product
prev
next
Leave a review
Claim listing
Bookmark
Share
Report
prev
next
Indicaton
Hearing Loss
Therapeutic indications
Neurology
You may also be interested in
TOTIPHARMACEUTICAL
Polypharmacology for all therapeutic aeras using nano-drug delivery systems
Discovery
Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.
Insomnia
Marketed
Slenyto® (PedPRM) was approved by EMA for the treatment of insomnia in children and adolescents with Autism Spectrum Disorder (ASD) and / or Smith-Magenis syndrome.
Insomnia in ASD
Marketed
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept